Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Cell Reactant: | HIV-1 Protease Mutant (V82F/I84V) | ||
Syringe Reactant: | BDBM518 | ||
Meas. Tech.: | Isothermal Titration Calorimetry | ||
Entry Date: | 04/20/04 | ||
ΔG°: | -9.70± (kcal/mole) | ||
pH: | 5±n/a | ||
Log10Kb: | n/a | ||
Temperature: | 298.15±n/a (K) | ||
ΔH° : | 4.40±0.200 (kcal/mole) | ||
ΔHobs : | 4.35± (kcal/mole) | ||
Ionic Strength: | n/a | ||
not known | |||
Protons Released: | 0.4 | ||
ΔCp : | -0.41±0.04 (kcal/mole) | ||
Stoich. Param.: | n/a | ||
ΔS° : | 0.0500± (kcal/mole-K) | ||
Comments: | n/a | ||
Citation | Todd, MJ; Luque, I; Velázquez-Campoy, A; Freire, E Thermodynamic basis of resistance to HIV-1 protease inhibition: calorimetric analysis of the V82F/I84V active site resistant mutant. Biochemistry39:11876-83 (2000) [PubMed] Article | ||
More Info.: | Get all data from this article , ITC RUN data , Solution Info , Data Fit Method , Instrument Info | ||
HIV-1 Protease Mutant (V82F/I84V) | |||
Source: | mutations at position 82 and 84 were introduced using an in vitro site-directed mutagenesis kit, mutant protease was expressed in BL21/DE3 | ||
Purity: | 99% | ||
Prep. Method: | HIV-1 protease was purified and refolded from E. coli inclusion bodies. | ||
Name: | HIV-1 Protease Mutant (V82F/I84V) | ||
Synonyms: | n/a | ||
Type: | Protein Complex | ||
Mol. Mass.: | n/a | ||
Description: | n/a | ||
Components: | This complex has 2 components. | ||
Component 1 | |||
Name: | HIV-1 Protease Mutant (V82F/I84V) chain A | ||
Synonyms: | HIV-1 Protease Mutant (V82F/I84V) chain B | ||
Type: | Enzyme Subunit | ||
Mol. Mass.: | 10816.23 | ||
Organism: | Human immunodeficiency virus type 1 | ||
Description: | Using plasmid-encoded mutant protease (Q7K/L33I/L63I designed to remove three hypersensitive autolytic sites) for the stability of protease. | ||
Residue: | 99 | ||
Sequence: |
| ||
Component 2 | |||
Name: | HIV-1 Protease Mutant (V82F/I84V) chain A | ||
Synonyms: | HIV-1 Protease Mutant (V82F/I84V) chain B | ||
Type: | Enzyme Subunit | ||
Mol. Mass.: | 10816.23 | ||
Organism: | Human immunodeficiency virus type 1 | ||
Description: | Using plasmid-encoded mutant protease (Q7K/L33I/L63I designed to remove three hypersensitive autolytic sites) for the stability of protease. | ||
Residue: | 99 | ||
Sequence: |
| ||
BDBM518 | |||
Source: | Purified from commercial capsules | ||
Purity: | n/a | ||
Prep. Method: | Further purified by HPLC using a semipreparative C-18 reversed-phase column developed with 0-100% acetonitrile in 0.05% TFA | ||
Name | BDBM518 | ||
Synonyms: | (3S,4aS,8aS)-N-tert-butyl-2-[(2R,3R)-2-hydroxy-3-[(3-hydroxy-2-methylphenyl)formamido]-4-(phenylsulfanyl)butyl]-decahydroisoquinoline-3-carboxamide | AG-1343 | CHEMBL584 | Nelfinavir | Viracept | ||
Type | Small organic molecule | ||
Emp. Form. | C32H45N3O4S | ||
Mol. Mass. | 567.782 | ||
SMILES | Cc1c(O)cccc1C(=O)N[C@@H](CSc1ccccc1)[C@H](O)CN1C[C@H]2CCCC[C@H]2C[C@H]1C(=O)NC(C)(C)C |@@:23| | ||
Structure |
Home |
| |
Search |
| |
Deposit |
| |
SiteMap |
| |
About us |
| |
Email us |
| |
Info |
|
©2000 BindingDB. All rights reserved. |